Evidence map›Paper›PMID 31770197›Full record

ArticleMedicine2019

Clinical significance of down-regulated HINT2 in hepatocellular carcinoma.

Dong-Kai Zhou, Xiao-Hui Qian, Jun Cheng, Ling-Hui Chen, Wei-Lin Wang

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Dong-Kai ZhouDepartment of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital.
Xiao-Hui QianDepartment of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital.
Jun ChengDepartment of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital.
Ling-Hui ChenDiagnosis and Treatment Center of Thyroid Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China.
Wei-Lin WangDepartment of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital.
Blood Center of Zhejiang Province · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To study the clinical significance of HINT2 expression in patients with HCC.We investigated HINT2 mRNA expression in tumors and adjacent non-tumor hepatic tissues from 106 HCC patients using quantitative real-time PCR. Appropriate statistical methods were then applied to assess the relationships between the HINT2 mRNA level and clinical parameters.HINT2 was significantly down-regulated in HCC (P < .0001). No significant correlation was found between HINT2 expression and clinicopathological factors in HCC patients. A Kaplan-Meier survival curve showed that HINT2 expression is related to recurrence-free survival (P < .05). Multivariate analyses revealed that tumor size and HINT2 expression are risk factors for HCC recurrence.HINT2 is down-regulated in HCC, and low HINT2 expression predicts earlier tumor recurrence. HINT2 expression may serve as a prognostic indicator of recurrence in HCC.

Indexed as

AgedBiomarkers, TumorCarcinoma, HepatocellularDown-RegulationFemaleGene Expression Regulation, NeoplasticHumansKaplan-Meier EstimateLiverLiver NeoplasmsMaleMiddle AgedMitochondrial ProteinsMultivariate AnalysisNeoplasm Recurrence, LocalPrognosisBiomarkers, TumorHint2 protein, humanMitochondrial ProteinsRNA, Messenger

Identifiers

PMID31770197
PMCPMC6890357
OpenAlexW2990234402

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.